Peer-reviewedCC BY 4.0Phytochemistry Letters
An unusual acyclic nor-triterpene derivative from Lacrymaria lacrymabunda mushroom active against methicillin-resistant Staphylococcus aureus (MRSA)
Abstract
An unusual linear nor-triterpene derivative named lacrymaric acid (1) was isolated from Lacrymaria lacrymabunda caps. This compound was revealed in TLC-bioautography as antibacterial against various Staphylococcus aureus strains, including methicillin-resistant clinical isolates (MRSA). The structure of 1 was unambiguously elucidated by spectroscopic analyses (HR-ESI-MS, 1D and 2D NMR) as an acyclic carboxylated nor-triterpene putatively derived from squalene.
Related
- Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point
- Two novel Silviavirus phages with lytic activity against methicillin-resistant Staphylococcus aureus: genomic and phenotypic characterization
- Preserving Nanotherapy-Induced Allogeneic Murine Islet Graft Tolerance During Distal Methicillin-Resistant Staphylococcus aureus Skin Infection
- Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database
- A truncated nisin variant, lipidated at its C-terminus, displays improved stability and increased antibacterial activity against methicillin-resistant Staphylococcus aureus
BibTeX
@article{ozga2026unusual,
title = {{An unusual acyclic nor-triterpene derivative from Lacrymaria lacrymabunda mushroom active against methicillin-resistant Staphylococcus aureus (MRSA)}},
author = {Théo Ozga and Franck Cantet and Jean-Michel Bellanger and Matteo Bonazzi and Aurélie Urbain},
journal = {Phytochemistry Letters},
year = {2026},
month = sep,
doi = {10.1016/j.phytol.2026.104226},
url = {https://hal.science/hal-05743556v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - An unusual acyclic nor-triterpene derivative from Lacrymaria lacrymabunda mushroom active against methicillin-resistant Staphylococcus aureus (MRSA)
AU - Théo Ozga
AU - Franck Cantet
AU - Jean-Michel Bellanger
AU - Matteo Bonazzi
AU - Aurélie Urbain
PY - 2026
DA - 2026/09/09
JO - Phytochemistry Letters
DO - 10.1016/j.phytol.2026.104226
UR - https://hal.science/hal-05743556v1
AB - An unusual linear nor-triterpene derivative named lacrymaric acid (1) was isolated from Lacrymaria lacrymabunda caps. This compound was revealed in TLC-bioautography as antibacterial against various Staphylococcus aureus strains, including methicillin-resistant clinical isolates (MRSA). The structure of 1 was unambiguously elucidated by spectroscopic analyses (HR-ESI-MS, 1D and 2D NMR) as an acyclic carboxylated nor-triterpene putatively derived from squalene.
SN - 1874-3900
ER -